imperatorin has been researched along with Cardiomegaly in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Y; Duan, H; He, L; Zhan, Y; Zhang, Y | 1 |
| Cao, Y; Duan, H; He, L; Wang, H; Zhang, Y | 1 |
2 other study(ies) available for imperatorin and Cardiomegaly
| Article | Year |
|---|---|
Furanocoumarins-imperatorin inhibits myocardial hypertrophy both in vitro and in vivo.
Topics: Angiotensin II; Animals; Cardiomegaly; Cardiovascular Agents; Cells, Cultured; Furocoumarins; Heart Failure; Molecular Structure; Myocardium; Myocytes, Cardiac; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley | 2010 |
Imperatorin prevents cardiac hypertrophy and the transition to heart failure via NO-dependent mechanisms in mice.
Topics: Animals; Atrial Natriuretic Factor; Cardiomegaly; Cells, Cultured; Cytoplasmic Dyneins; Furocoumarins; Gene Expression Regulation; Heart Failure; Male; Mice; Myocytes, Cardiac; Natriuretic Peptide, Brain; Nitric Oxide; Nitric Oxide Synthase Type III; Rats; Sarcoplasmic Reticulum Calcium-Transporting ATPases | 2012 |